ATE271406T1 - Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils - Google Patents

Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils

Info

Publication number
ATE271406T1
ATE271406T1 AT01975262T AT01975262T ATE271406T1 AT E271406 T1 ATE271406 T1 AT E271406T1 AT 01975262 T AT01975262 T AT 01975262T AT 01975262 T AT01975262 T AT 01975262T AT E271406 T1 ATE271406 T1 AT E271406T1
Authority
AT
Austria
Prior art keywords
conjugated fatty
hypercholesterolemia
body fat
insulin sensitivity
chrome
Prior art date
Application number
AT01975262T
Other languages
English (en)
Inventor
David P Katz
James R Komorowski
Danielle Greenberg
Original Assignee
Nutrition 21 Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 Inc filed Critical Nutrition 21 Inc
Application granted granted Critical
Publication of ATE271406T1 publication Critical patent/ATE271406T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT01975262T 2000-09-21 2001-09-20 Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils ATE271406T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23447400P 2000-09-21 2000-09-21
US29668801P 2001-06-06 2001-06-06
PCT/US2001/029422 WO2002024180A2 (en) 2000-09-21 2001-09-20 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia

Publications (1)

Publication Number Publication Date
ATE271406T1 true ATE271406T1 (de) 2004-08-15

Family

ID=26927971

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01975262T ATE271406T1 (de) 2000-09-21 2001-09-20 Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils

Country Status (9)

Country Link
US (4) US6809115B2 (de)
EP (1) EP1357977B1 (de)
JP (1) JP2004509143A (de)
CN (1) CN1665566A (de)
AT (1) ATE271406T1 (de)
AU (1) AU2001294602A1 (de)
DE (1) DE60104450T2 (de)
ES (1) ES2223924T3 (de)
WO (1) WO2002024180A2 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001527022A (ja) * 1997-07-14 2001-12-25 ラジュ、ジー・ガンガ ヒドロキシクエン酸組成物、前記組成物から製造された補助医薬品及び補助食品及び食品並びに体重を低減させることにおけるそれらの使用方法
US20030228347A1 (en) * 2000-09-12 2003-12-11 Clark George H. Amino acid chelate for the effective supplementation of calcium magnesium and potassium in the human diet
US20040157929A1 (en) * 2002-04-01 2004-08-12 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating(-)hydroxycitric acid, and related compositions thereof
CA2448241A1 (en) * 2001-05-31 2002-12-05 Wisconsin Alumni Research Foundation Conjugated nonadecadienoic acid compositions
US7119110B2 (en) * 2001-10-05 2006-10-10 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
US6888016B2 (en) * 2001-10-16 2005-05-03 Loders Croklaan Usa Llc Mixtures for stimulating glucose up-take
US20030119913A1 (en) * 2001-12-20 2003-06-26 Ohia Sunny E. Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
DE10226018A1 (de) * 2002-06-12 2003-12-24 Cognis Deutschland Gmbh Zubereitungen mit konjugiertem Linolalkohol
ATE349918T1 (de) * 2002-07-01 2007-01-15 Unilever Nv Zusammensetzung, die ein sättigungsgefühl hervorruft
KR100523446B1 (ko) * 2002-08-23 2005-10-25 주식회사 엠디바이오알파 유향으로부터 얻은 5' 에이엠피-활성화 단백질 인산화효소 활성용 추출물
RU2277918C2 (ru) * 2002-09-20 2006-06-20 Сергей Ростиславович Соколовский Способ лечения ожирения
IL152397A (en) * 2002-10-21 2009-02-11 Hadasit Med Res Service Compositions and compounds for the treatment of hyperglycemia
NZ539777A (en) 2002-11-04 2008-02-29 Ocean Nutrition Canada Ltd Microcapsules having multiple shells and method for the preparation thereof
US20060171992A1 (en) * 2002-12-20 2006-08-03 Gerhardt Cinderella C Blood glucose regulating composition
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
TW200518768A (en) * 2003-11-17 2005-06-16 Pepgen Corp Methods for treatment of obesity and for promotion of weight loss
US20060029642A1 (en) 2004-08-03 2006-02-09 Dusan Miljkovic Methods and compositions for improved chromium complexes
US7297686B2 (en) * 2004-11-16 2007-11-20 Hwang David L Chromium complex with insulin-like activity
GB0426264D0 (en) * 2004-11-30 2004-12-29 Trigen Ltd Compounds
US8034450B2 (en) * 2005-01-21 2011-10-11 Ocean Nutrition Canada Limited Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
WO2006117675A1 (en) * 2005-01-27 2006-11-09 Ocean Nutrition Canada Ltd. Fatty acid-benzenediol derivatives and methods of making and using thereof
EP1848729A2 (de) * 2005-01-27 2007-10-31 Ocean Nutrition Canada Limited Chrom-fettsäureverbindungen und verfahren zu ihrer herstellung und verwendung
GB0514463D0 (en) 2005-01-31 2005-08-17 Loders Croklaan Bv Use of pinolenic acid
US9968120B2 (en) 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
WO2007109845A1 (en) * 2006-03-28 2007-10-04 Medical Therapies Limited Prophylaxis or treatment of diabetes
AU2007238985B2 (en) * 2006-04-07 2012-09-20 Dsm Nutritional Products Ag Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
WO2007127867A2 (en) * 2006-04-26 2007-11-08 Mandrillus Pharma, Llc Chromium complexes
JP5979697B2 (ja) 2006-06-05 2016-08-24 ディーエスエム ニュートリショナル プロダクツ アーゲーＤＳＭ Ｎｕｔｒｉｔｉｏｎａｌ Ｐｒｏｄｕｃｔｓ ＡＧ 改善された殻を有するマイクロカプセル
JP5045879B2 (ja) * 2006-06-07 2012-10-10 株式会社龍泉堂 インスリン抵抗性の改善効果、体重増加の抑制効果、及び脂肪肝の予防及び改善効果を有する混合物
US20090203780A1 (en) * 2006-06-27 2009-08-13 Luisa Gambelli Use of a Polyunsaturated Fatty Acid Compound
WO2008139261A2 (en) * 2006-11-03 2008-11-20 Pronova Biopharma Norge As Omega-3 lipid compound
JP2010515455A (ja) 2007-01-10 2010-05-13 オーシャン ニュートリッション カナダ リミテッド 菜食マイクロカプセル
CA3021932C (en) * 2007-01-31 2020-12-15 Jds Therapeutics, Llc Use of chromium histidinate for treatment of cardiometabolic disorders
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
ES2579229T3 (es) * 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
JP2010202634A (ja) * 2008-06-05 2010-09-16 Green Kanpo Seiyaku Kk 生薬含有組成物及びその利用
TWI454221B (en) * 2008-07-14 2014-10-01 Composition and method for inhibiting formation of body fat
WO2010105239A1 (en) * 2009-03-13 2010-09-16 Russell Kenneth O Method for enhancing insulin mediated uptake of nutrients into cells
US9028879B2 (en) * 2009-07-01 2015-05-12 Jds Therapeutics, Llc Chromium complexes as enhancers of brain glucose transporters
RU2013133994A (ru) * 2010-12-21 2015-01-27 Нестек С.А. Способы и композиции, применимые для контроля глюкозы в крови животных
AU2012223282B2 (en) 2011-03-01 2017-02-02 Nutrition 21, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
US20130344007A1 (en) * 2012-06-26 2013-12-26 Yl Holdings, Inc. Frankincense chewing gum
CN103082298B (zh) * 2013-01-17 2014-08-13 吉林省中药制剂工程研究中心有限公司 一种用于辅助降糖的保健食品及其制备方法
US10744070B2 (en) 2015-06-19 2020-08-18 University Of Southern California Enteral fast access tract platform system
US10631564B2 (en) 2015-06-19 2020-04-28 University Of Southern California Enterically coated microparticle compositions and methods for modified nutrient delivery
EA031455B1 (ru) * 2015-08-03 2019-01-31 Республиканское Государственное Предприятие На Праве Хозяйственного Ведения "Северо-Казахстанский Государственный Университет Имени Манаша Козыбаева" Эмульсионный лекарственный препарат
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
CN109475635A (zh) * 2016-03-15 2019-03-15 玛丽女王伦敦大学 治疗肥胖症的方法
US10820617B1 (en) 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement
CN111568889A (zh) * 2020-06-12 2020-08-25 四川大学华西医院 羟基十八碳二烯酸在制备α-葡萄糖苷酶抑制剂类药物的用途及其分离方法
CN115245510A (zh) * 2021-04-28 2022-10-28 扬州大学 反式-10，顺式-12共轭亚油酸的用途
CN120919090B (zh) * 2025-10-16 2025-12-23 山东第一医科大学附属省立医院(山东省立医院) 愈创木酚或其衍生物在制备预防或治疗代谢综合征药物中的应用

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248607A1 (de) * 1972-10-04 1974-04-11 Wacker Chemie Gmbh Verfahren zur herstellung von polyvinylhalogeniden
US3899476A (en) 1974-04-29 1975-08-12 Westvaco Corp Process for making a methacrylic acid adduct of linoleic acid and product
US3923768A (en) 1974-11-18 1975-12-02 Westvaco Corp Treatment of tall oil fatty acids
US4056637A (en) 1976-06-08 1977-11-01 Japan Natural Food Co. Ltd. Process for preparing food products containing a lactic acid bacteria-fermented product of a cereal germ
FR2474310A1 (fr) 1980-01-25 1981-07-31 Oreal Solution stable a l'oxydation de vitamine f et d'huile de jojoba et compositions cosmetiques la contenant
USRE33988E (en) 1980-08-08 1992-07-07 The United States of America as repesented by the Secretary of Agriculture Dietary supplementation with essential metal picolinates
FR2490631A1 (fr) 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
US5194615A (en) 1983-07-08 1993-03-16 The William Seroy Group Synthetic GTF chromium nicotinate material and its preparation
US4954492A (en) 1983-07-08 1990-09-04 The William Seroy Group Synthetic GTF chromium material for decreasing blood lipid levels and process therefor
US4871768A (en) 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US5175156A (en) 1987-11-30 1992-12-29 Nutrition 21 Chromic picolinate treatment
US5087623A (en) 1988-05-31 1992-02-11 Nitrition 21 Chromic picolinate treatment
US5070104A (en) 1989-02-17 1991-12-03 Wisconsin Alumni Research Foundation Methods of chelating metal and novel compositions therefor
US5208356A (en) 1989-02-17 1993-05-04 Wisconsin Alumni Research Foundation Octadecadienoic phospholipic esters, antioxidant and mold inhibiting compositions
US5017614A (en) 1989-02-17 1991-05-21 Wisconsin Alumni Research Foundation Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth and novel compositions therefor
US5087624A (en) 1989-03-21 1992-02-11 Nutrition 21 Chromic picolinate treatment
US5033534A (en) * 1990-03-02 1991-07-23 Nkk Corporation Method for continuous casting of steel
US5053534A (en) 1990-10-11 1991-10-01 Westvaco Corporation Process for making a dicarboxylic acid
US5194640A (en) 1991-06-10 1993-03-16 Westvaco Corporation Process for making high-purity oleic acid
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
US5428072A (en) 1992-04-29 1995-06-27 Wisconsin Alumni Research Foundation Method of increasing the efficiency of feed conversion in animals
US5554646A (en) 1992-04-29 1996-09-10 Wisconsin Alumni Research Foundation Method for reducing body fat in animals
US5430066A (en) 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5543405A (en) 1993-10-22 1996-08-06 Keown; Wendy J. Composition and method for weight reduction and long term management of obesity
US5855949A (en) 1994-01-10 1999-01-05 Mclean; Linsey Dietary system high in oil intake
US5814663A (en) 1994-08-29 1998-09-29 Wisconsin Alumni Research Foundation Method for maintaining an existing level of body fat
US5760082C1 (en) 1994-08-29 2001-03-06 Wisconsin Alumni Res Found Dietetic foods containing conjugated linoleic acids
US5890905A (en) * 1995-01-20 1999-04-06 Bergman; Marilyn M. Educational and life skills organizer/memory aid
FR2729957B1 (fr) 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
US6329361B1 (en) 1995-05-12 2001-12-11 Nutrition 21 High-dose chromic picolinate treatment of type II diabetes
US5856149A (en) 1995-06-01 1999-01-05 Wisconsin Alumni Research Foundation Method of producing conjugated fatty acids
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
DE69615513T2 (de) 1995-11-14 2002-05-08 Unilever N.V., Rotterdam Essbarer Brotaufstrich
ES2148814T5 (es) 1995-11-14 2005-12-16 Loders Croklaan B.V. Procedimiento para la preparacion de materiales con un alto contenido de isomeros de acido linoleico conjugado.
US5804210A (en) 1996-08-07 1998-09-08 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein
US5866560A (en) * 1996-08-20 1999-02-02 Schering Ag 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
US5770247A (en) 1996-10-03 1998-06-23 Wisconsin Alumni Research Foundation Method of increasing the CLA content of cow's milK
JP3017108B2 (ja) 1996-10-30 2000-03-06 リノール油脂株式会社 共役リノール酸の製造方法
US5855917A (en) 1996-12-04 1999-01-05 Wisconsin Alumni Research Foundation Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids
EP1021177A4 (de) 1997-02-04 2002-05-15 John V Kosbab Zusammensetzungen und verfahren zur verhütung und behandlung von vaskulär-degeneratieve krankheiten
US5892074A (en) 1997-02-18 1999-04-06 Seidel; Michael C. Synthesis of conjugated linoleic acid (CLA)
US6153774A (en) 1997-02-18 2000-11-28 Seidel; Michael C. Silver ion chromatography of high purity conjugated linoleic acid (CLA)
US5837733A (en) 1997-02-26 1998-11-17 Wisconsin Alumni Research Foundation Method for reducing secetion of apolipoprotein B in animals by administering conjugated linoleic acid
US5851572A (en) 1997-04-25 1998-12-22 Wisconsin Alumni Research Foundation Method of increasing fat firmness and improving meat quality in animals with conjugated linolenic acid
US6060087A (en) 1997-04-25 2000-05-09 Wisconsin Alumni Research Foundation Method of increasing fat firmness and improving meat quality in animals
US5789401A (en) 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
JPH11209279A (ja) 1998-01-05 1999-08-03 Natural Ltd As 体重減少および肥満処置の方法
US6042869A (en) 1998-02-20 2000-03-28 Natural Nutrition Ltd. Bulk animal feeds containing conjugated linoleic acid
US6020377A (en) 1998-03-13 2000-02-01 Kansas State University Research Foundation Modified tall oil supplemented diet for growing-finishing pigs
US6015833A (en) 1998-03-17 2000-01-18 Conlinco., Inc. Conjugated linoleic acid compositions
US6077525A (en) 1998-04-10 2000-06-20 The George Washington University Use of conjugated linoleic acids
US6113973A (en) 1998-04-15 2000-09-05 Wisconsin Alumni Research Foundation Eggs enriched with conjugated linoleic acid
US6177580B1 (en) 1998-04-21 2001-01-23 Henkel Kommanditgesellschaft Auf Aktien Conjugated linolenic acid-based synthetic triglycerides
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
US6214372B1 (en) 1998-05-04 2001-04-10 Con Lin Co., Inc. Method of using isomer enriched conjugated linoleic acid compositions
US6060514A (en) 1998-05-04 2000-05-09 Conlin Co., Inc. Isomer enriched conjugated linoleic acid compositions
WO1999056780A1 (en) 1998-05-04 1999-11-11 Conlinco, Inc. Isomer enriched conjugated linoleic acid compositions
FI111513B (fi) 1998-05-06 2003-08-15 Raisio Benecol Oy Uudet fytosteroli- ja fytostanolirasvahappoesterikoostumukset, niitä sisältävät tuotteet sekä menetelmät niiden valmistamiseksi
US5948772A (en) * 1998-08-28 1999-09-07 Ambi Inc. Chromium picolinate compositions and uses thereof
US5980905A (en) * 1998-08-28 1999-11-09 Ambi Inc. Chromium polynicotinate compositions and uses thereof
WO2000012080A1 (en) 1998-09-01 2000-03-09 Amway Corporation Diet composition and method of weight management
US6019874A (en) 1999-01-19 2000-02-01 Berg; Lloyd Separation of conjugated linoleic acids by azeotropic distillation
US6020378A (en) 1999-03-30 2000-02-01 Wisconsin Alumni Research Foundation Method for selectively altering body fat level, feed efficiently, or weight gain
US6342619B2 (en) * 1999-04-01 2002-01-29 Michael C. Seidel Synthesis of conjugated fatty acid
AU2437101A (en) * 1999-12-16 2001-06-25 Harry Siskind Nutritional composition, methods of producing said composition and methods of using said composition
AU2000265108A1 (en) 2000-08-02 2002-02-13 Pharmanutrients Methods and compositions for the attenuation and/or prevention of stress/catabolic responses
AU2000265107A1 (en) 2000-08-02 2002-02-13 Pharmanutrients Methods and compositions for the prevention and treatment of inflamation, osteoarthritis, and other degenerative joint diseases
EP1305018A4 (de) 2000-08-02 2006-08-30 Pharmanutrients Methoden und zusammenstellungen zur prophylaxe und/oder behandlung von diabetes und zur glukoseregulierung
JP2004505041A (ja) 2000-08-02 2004-02-19 ファーマニュートリエンツ シンドロームｘの予防及び治療のための方法及び組成物

Also Published As

Publication number Publication date
US20060204517A1 (en) 2006-09-14
ES2223924T3 (es) 2005-03-01
WO2002024180A2 (en) 2002-03-28
AU2001294602A1 (en) 2002-04-02
US20030091654A1 (en) 2003-05-15
US6809115B2 (en) 2004-10-26
CN1665566A (zh) 2005-09-07
EP1357977B1 (de) 2004-07-21
US20060204518A1 (en) 2006-09-14
DE60104450D1 (de) 2004-08-26
US20090060941A9 (en) 2009-03-05
US20090136539A9 (en) 2009-05-28
DE60104450T2 (de) 2005-09-15
JP2004509143A (ja) 2004-03-25
US20020081315A1 (en) 2002-06-27
EP1357977A2 (de) 2003-11-05
WO2002024180A3 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
ATE271406T1 (de) Chrom enthaltende zusammensetzung zur behandlung von diabetes, zur verbesserung der insulinsensitivität und zur reduktion von hyperglykämie, hypercholesterolämie und des körperfettanteils
NO20003051L (no) Metode for administrering av AspB28-humant insulin
BR0015974A (pt) Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
DE69930252D1 (de) Verwendung von tetracyclinen zur behandlung von störungen der meibomschen drüsen
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE503490T1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
DE69226835D1 (de) Verfahren und zusammensetzungen zur behandlung von diabetes mellitus, hypoglykämie und anderer krankhafter zustände
DE69926400D1 (de) Zusammensetzung enthaltend insulin-sensibilisierenden wirkstoffe und inhibitoren der fruktose-1,6-bisphosphatase (fbpase) zur behandlung von diabetes
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
ATE290863T1 (de) Verwendung von prolactinmodulatoren und diät zur herstellung eines medikamentes zur behandlung der fettleibigkeit
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법
KR890004690A (ko) 당뇨병의 치료를 위한 베자피브레이드의 용도
WO2003043569A3 (en) Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases
KR930019224A (ko) 유산 위험 치료제
DE60229240D1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
RU96115219A (ru) Способ лечения больных сахарным диабетом
DE69221725D1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ATE409042T1 (de) Verwendung von sulodexide zur behandlung von diabetischer nephropathie
EA200600757A1 (ru) Тетрапептид, регулирующий уровень глюкозы в крови при сахарном диабете
DE60122781D1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
ATE310525T1 (de) Verwendung von sulfatiden zur behandlung von diabetes
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
EP1274452A4 (de) Methode zur prävention und behandlung von diabetes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties